Enhancing Patient Outcomes with MIGS and SLT
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
Glaucoma, a leading cause of blindness, is witnessing significant advancements in treatment. The evolution in minimally invasive glaucoma surgeries (MIGS) and laser therapies like selective laser trabeculoplasty (SLT) have reshaped patient care. This article delves into recent developments, aiming to keep eye health professionals at the forefront of glaucoma management.
Learning Objectives
- Understanding recent developments to assist with Glaucoma management
- How Glaucoma patients can benefit with MIGS and SLT.
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Enhancing Patient Outcomes with MIGS and SLT |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |